The product was packaged specifically to prevent the issue that the FDA has just assigned with its second-highest risk level.
In its upcoming report, Procter & Gamble (PG) is predicted by Wall Street analysts to post quarterly earnings of $1.87 per share, reflecting an increase of 1.6% compared to the same period last year.